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Abstract
Inducible cAMP early repressor (ICER) is an endogenous repressor of cAMPresponsive element (CRE) with antiproliferative properties that acts as a potential
suppresser for tumors especially melanoma. ICER activity and cellular localization are
orchestrated by the performance o f the post-translational modifications (PTMs).
Ubiquitination and sumoylation are two o f the most important types o f PTMs that control
diverse groups of biological processes for ICER protein. The goal of this project is to study
how post-translational modifications alter the function o f the transcriptional repressor
Inducible cAMP Early Repressor (ICER) in melanoma cells. Since ICER ubiquitination
and sumoylation processes take place on the interaction between the ubiquitin and the
lysine residues of ICER amino acid sequence, my interest was focused on the downstream
targets of each ICER mutants. Through the application o f site-directed mutation to the
multiple ubiquitination positions o f the amino acid Lysine (K) and replacing them by
Arginine (R). Then, ICER’s wild type and mutant DNA were transfected into human
mammalian model melanoma cells; SK-MEL-24 and subjected to immunocytochemistry,
Western Blot and half-life analyses to further understand the modification and regulatory
nature of ubiquitination and sumoylation pathways. The results presented an insight on the
cellular distribution of ICER mutants’ expression as well as hinted at the importance of
ubiquitination and sumoylation in terms o f ICER stability.
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Introduction
Although many people might think that all important human body’s organs are
embedded internally, our skin; on the other hand, is the external coat that surrounds our
flesh and shapes our familiar human body appearance. Because human skin is considered
the largest and the heaviest of all other organs, its significance goes beyond its role in
making us look presentable in an intact human figure (1). Our skin not only maintains the
normal body moisture, it also insulates and guards it against the harsh environment
conditions such as temperature, sunlight damage and chemicals. In addition, our skin
secrets different types of substances that protects it against various numbers o f infections
caused by bacteria or other invading microorganisms (2). Furthermore, the skin is our main
source of vitamin D production, the key sensory center in our bodies and an essential tool
for free body movements. Hence, our skin provides crucial and versatile functions allowing
us to survive and live a healthy life (2).
However, skin -like any other organ- is highly susceptible to several diseases and
abnormalities that require fast therapeutic care to prevent serious consequences which
might lead to sudden death (3). One o f the most common skin diseases is melanoma or skin
cancer (4). It results from an uncontrolled differentiation o f melanocyte cells with
unlimited ability to invade the nearby healthy tissues and form cancerous lesions (4).
Melanocytes are specialized cells found in the epidermal layer o f the skin that is
responsible for the production of the brown pigmentation of our skin known as melanin.
They are also responsible for generating different skin colors with remarkable variations
as well as the production of moles (5). Melanoma has two stages o f development; the first
stage is called benign and can be treated and controlled, the second stage called malignant
1

and results when the patient at the benign stage is left untreated (6). Melanoma occurs due
to abnormal genetic mutations in the melanocytes (7). The process begins in the skin where
a mole containing melanocyte cells is activated by UV radiation (7). When the tumor
becomes invasive, it grows and penetrates vertically affecting other vital organs through a
process called metastasis (8). The main cause o f mutation is still not very clear, but recent
research studies have confirmed that it could be due to the direct exposure to the sunlight,
which contains an ultraviolet (UV) radiation that destroys or alters the melanocytes in such
a way that lead to an over-expression and consequently unlimited cellular divisions (9).
Some research studies have also suggested that melanoma may develop from the fact that
this disease can be genetically inherited from one or two parents who happened to have
melanoma or other types of cancer (10). Melanoma can differ by gender in terms of
location; in men, it might be found in the trunk area o f the body and in women it can most
likely be found on the back and leg areas (11). Melanoma can also differ by percentage
between men and women and it has been estimated that men are more likely to develop
melanoma than women by a factor of 55%. Epidemiologists have also confirmed that
melanoma is ranked as the sixth and seventh leading cause o f mortality in men and women,
respectively (11). Moreover, in a new statistical study conducted in the United States in
2016 the total number of new melanoma cases was estimated to reach 76,380 with
California (8,560) and Florida (6,200) scoring the highest numbers followed by New York
(4,250) and Pennsylvania (3,750) (12). In addition to gender, race and age play critical
roles in melanoma susceptibility. For instance, Caucasian individuals are more prone to
have melanoma due to the fair skin that produces lower amounts o f melanin pigmentation
that is essential to protect against UV exposure (5). Furthermore, an individual’s age can
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also indicate the predisposition to melanoma whereas it has been estimated that adults
between 55 to 74 years-old are the most affected group (5).
In recent years, the incidence o f melanoma has continued to increase rapidly.
Scientists have been searching for new methods to eradicate this disease. Many on-going
research studies and clinical trials have been used and practiced in the treatment of
melanoma resulting in slightly reduced patient susceptibility but not curing the patients (4).
Different approaches can be applied in the hopes to specifically target cancerous cells and
effectively kill them can be divided into two groups; the first involves the use of the
traditional approaches which includes: chemotherapy, radiation, and surgery (13). While
the second involves the application o f modem molecular approach that utilizes stem cells,
bone marrow transplanting, immunotherapy and gene therapies that are clinically designed
to target specific genes and proteins, in cancer cells, that directly participate in cellular
mechanisms such as uncontrolled cell proliferation, declined apoptotic levels and unlimited
tumor growth (13,14). The focus o f this project is on the gene therapy approach to study
and investigate melanoma cells in vitro using human model cancer cells.
Previous studies have suggested that the development o f melanoma and other
cancer types relate directly to one o f the most critical cellular processes called
posttranslational modification (PTM) (15). Those processes, along with protein
degradation, allow rapid regulation o f different physiological processes in a way that
maintains body homeostasis by means o f adaptation to the surrounding environments.
Therefore, PTMs provide specific and effective biological responses to either external or
internal stimuli which make them responsible for altering protein function, activity,
stability and their subcellular localization (16). PMTs modify proteins by attaching or
3

tagging a variety of functional groups to their targeted amino acid sequences in order to
interfere with their function or structure and consequently regulate them to serve cellular
demands (16). Moreover, PTMs are divided into two types; reversible and irreversible.
Among all identified reversible PTMs in mammals, ubiquitination and sumoylation are two
of the most frequent modifications that regulate the activity of proteins (16). The function
of ubiquitination is to recognize and covalently attach to lysine (K) residues o f a protein
with ubiquitin, a small protein of 76 amino acids with a molecular weight o f 8.5 KDa that
is expressed widely in all mammalian tissues. The C-terminus o f the ubiquitin contains
glycine that is critical for its attachment to a substrate as well as to another ubiquitin
molecule (17). The attachment employs a set o f three enzymes; ubiquitin activating enzyme
(E l), ubiquitin conjugating enzyme (E2), and ubiquitin ligase (E3). The process begins
when El forms a thio-ester bond with the ubiquitin and leads to the binding o f ubiquitin to
E2, which in turn, allows the formation o f an isopeptide bond between the lysine residue,
which is required for further formation o f the polyubiquitin, and the c-terminus o f the
ubiquitin and requires E3 (18).These ubiqitinated proteins are either polyubiquitinated
forming a chain and allowing the cell to signal for protein unfolding and degradation
through proteasome multi-subunit or monoubiquitinated to a smaller fragment that
undergoes endocytosis, involved in DNA damage or even altering the subcellular
localization (19). After the protein is degraded, the ubiquitin dissociates through
deubiquitinating process and cycles back to be used again by the cell whenever is needed
(16).
On the other hand, sumoylation also labels the protein with a small ubiquitin-like
m otif with a molecular weight of 10 KDa, hence the name, however, it does not degrade
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the protein, rather, it regulates the functional properties o f proteins which involve
subcellular targeting and protein-protein interactions (20, 21).
Furthermore, research studies suggested that ubiquitination and sumoylation are
dysregulated leading to tumor growth and tumorigenesis, which includes an abnormal
progression of cell cycle, programmed cell death, and blocking different types o f crucial
receptors (21). Therefore, researchers and scientists spent great effort to understand and
investigate the molecular and biological basis of these two processes in the field of cancer
and especially in melanoma raising the potential that these pathways can be employed for
the therapeutic practices in order to eradicate cancer (21).
The goal of this project is to study and investigate how the two post-translational
modifications; ubiquitination and sumoylation can alter the function and cellular
localization of the transcriptional repressor Inducible cAMP Early Repressor (ICER) in
human melanoma cells. ICER is a part o f the transcription factor o f the cyclic AMP
response element (CRE) binding protein (CREB) and CRE modulator (CREM) (22).
CREB and CREM are phosphorylated by protein kinase A (PKA), which in turn, indirectly
activates the transcription of ICER and other CRE-involving proteins (23). ICER acts as a
transcript and auto-regulates CREM and has been found in four discrete isoforms,
including; ICER-I, ICER-II, ICER-Iy and ICER-IIy (23, 24). ICER has a protein structure
consisting of leucine zipper with a molecular weight o f-18.5 KDa (25). ICER only contains
a homodimer of DNA binding domain (DBD) allowing it to function as a strong dominant
negative transcriptional repressor for cAMP (26). Since ICER has neither activation
domain nor the phosphorylation (P)-box site, its protein activity can be detected through
its intracellular concentration which in turn relies on ICER degradation levels (25).
5

Previous studies have shown that ubiquitination and sumoylation are the two main
pathways for ICER degradation (25). Furthermore, previous evidence showed that ICER
abnormal protein expression is involved in tumorigenesis because its levels drop in human
cancer cells due to phosphorylation by either mitogen-activated protein (MAP) kinase
which leads to ubiquitin-mediated proteasomal degradation of ICER or by mitotic kinase
cdkl which results in monoubiquitination o f ICER causing it to mis-locate in the cytoplasm
(27). In addition, altering the enzymatic system o f sumoylation pathway upon intracellular
or extracellular stimuli or cellular transduction with other post-translational modification
mechanisms like ubiquitination leads to imbalanced transcriptional activities which in turn
results in melanoma progression (28). Even though the isoform ICER-IIy has the functional
characteristics of a tumor suppressor, there is no genetic evidence to demonstrate that ICER
is a tangible tumor suppressor gene product (29). Moreover, studies have indicated that the
proliferative characteristics of the melanocyte cells are mainly regulated by the cAMP
pathway where ICER is directly involved in the activation o f cell cycle (30).
Our interest was focused on the downstream targets o f each ICER mutant. This was
accomplished by applying site-directed mutation where eleven ubiquitination positions,
including K0-(52, 59, 70, 71, 72, 76, 87, 90, 97, 100 and 106) o f the amino acid Lysine (K)
were replaced by Arginine (R) in ICER protein. ICER’s wild type and mutant DNA were
transfected into the mammalian model melanoma cells SK-MEL-24. Then, a series of in
vitro analyses with both wild type and mutated ICER were conducted using Western blot,
and half-life techniques in order to investigate whether these mutations are affected by
ubiquitination and sumoylation.
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Materials and Methods
Cell line and culture
The cells were purchased from the American Type Culture Center company. The
SK-MEL-24 cells were harvested from the skin tissue o f a 76-old Caucasian male’s lymph
node who developed malignant melanoma. The media was nourished with Earle's BSS with
nonessential amino acids and sodium pyruvate, 85%; fetal bovine serum, 15% and
preserved in 5% DMSO (34).

Site-directed Mutagenesis and DNA vector of ICER-Iy mutants
ICER mutants were prepared by Fanaye Woldeamanuel (36) who previously
worked on the research where the ubiquitination sites o f ICER were first located and
represented by the amino acid lysine (K) at 11 positions as follows (Picture 1):
M A VT GDET A A 10
SPQQLAEEAT50
RVAVLEKQNK90

TGDMPTYQIR20
RKRELRLMKN60
TLIEELKALK100

APTTALPQGV30
REAARECRRK70
DLYCHKAE110

VMAASPGSLH40
KKEYVKCLEN80

Picture 1: Amino acid sequence of ICER. The ubiquitination sites of ICER represented by the Lysine residue (K) and
were highlighted in red.

Then a site-directed mutagenesis procedure was carried out and each lysine (K)
residue was replaced by arginine (R) residue and the knockout mutant was denoted as KO
followed by the position of the mutation as follows: KO-52, KO-59, K0-70, KO-71, KO-72,
KO-76, KO-87, K0-90, KO-97, K0-100 and K0-106, in addition to a mutant that had
mutation at all lysine (K) sites which was denoted as KO.
The vectors of ICER mutants were also designed and prepared by previous research
students where a cytomegalovirus (CMV) promoter was fused to a reporter with a group of
DNA fragment each containing an ICER mutant. The DNA vectors were designed and
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attached to the human influenza hemagglutinin (HA) epitope tag to further facilitate the
detection and identification of ICER mutants from other non-specific proteins after the
incubation with the anti-HA antibodies. To accomplish that, two groups were generated
where the HA-tag was placed on the N-terminus o f the DNA fragment including the
wildtype denoted as NWT, lysine knockout at all ubiquitination positions denoted as NKO
and lysine knockout at the following ICER ubiquitination positions denoted as: NKO-52,
NKO-59, NK0-70, NKO-71, NKO-72, NKO-76, NKO-87, NK0-90, NKO-97, NKO-100 and
NKO-106 and on the C-terminus of the DNA fragment including the wildtype denoted as
CWT and lysine knockout at all positions denoted as CKO. The stock solution of the 15
ICER constructs was then obtained from Invitrogen ™ Life Technologies company (35).

Non-Liposomal Transfection (Cationic liposome)
The SK-MEL-24 cell cultures were grown one day before so that the cells could be
confluent by the time the transfection was started. The DNA o f each ICER mutant was
diluted to 2pg per 100 pL of serum free media which contained phenyl red. Later the serum
free media was changed and 90pL of serum was used instead. Then 8pL o f fugene® HD
Transfection Reagent from Promoga company was added to each well and incubated for
20 minutes. There was a waiting period o f 48 hours before measuring the results. The total
volume of the DNA, serum and fugene® HD Transfection Reagent was calculated to be
lOOpL.

Indirect Avidin-Biotin Complex (ABC) Immunocytochemistry
As mentioned earlier, the cells were grown in culture plates and transfected. After
transfection, the medium was removed and the cells were washed 2 times with Phosphatebuffered saline (PBS) at room temperature. Then the cells were fixed by adding 4% (v/v)
8

formaldehyde in PBS using the same volume as the culture medium and incubated for 20
minutes. The fixative was removed and washed 3 times with PBS. Sodium Azide was used
in PBS to store the cells. The antigen retrieval buffer was reheated and 1 mL was added to
each cell culture. This mixture was heated at 95 °C for 10 minutes. The buffer was then
removed and cells were again washed 3 times with PBS. The cells were later incubated in
0.1% Triton X-100 in PBS for 15 minutes at room temperature. After the incubation, the
cells were rinsed 3 more times with PBS. Then the remaining PBS was removed and protein
block was applied to the cells. Then the cultures were incubated for 1 hour at room
temperature. Later, polyclonal Rabbit anti-HA (primary antibody) obtained from the
ab64261 - Rabbit Specific HRP/DAB (ABC) Detection IHC Kit was added and the cultures
at room temperature for 2 hours. After the incubation, the cells were washed 4 times with
2 mL PBS. Biotinylated Goat Anti-Polyvalent (secondary antibody) obtained from the
ab64261 - Rabbit Specific HRP/DAB (ABC) Detection IHC Kit was applied to the cells
and incubated for 10 minutes at room temperature and the cultures washed 4 times with
PBS. Later Streptavidin Peroxidase solution was then obtained from the ab64261 - Rabbit
Specific HRP/DAB (ABC) Detection IHC Kit, added to the cells and incubated for 10
minutes at room temperature. The cells were once again washed with PBS 4 times. One
drop of DAB Chromogen was added to 50 drops DAB substrate obtained from ab64261 Rabbit Specific HRP/DAB (ABC) Detection IHC Kit and this mixture was added to the
cells. The cells were incubated with the mixture for about 10 minutes and then rinsed 4
times with PBS. Finally, a drop of mounting medium was added to the slide and observed
under the microscope.
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NE-PER Nuclear and Cytoplasmic Extraction
The SK-MEL-24 cells were grown on a T25 flask and were transfected following
the same procedure previously mentioned. Then the culture medium was removed and the
cells were washed once with 2 mL PBS at room temperature. After that, 1 mL o f trypsinEDTA was added and the mix was incubated for 3 minutes at room temperature. Then, 2
mL of complete cell culture media was added to the cultures and mixed by pipetting up
and down gently. The mixture was transferred to a 15 mL tube and centrifuged at 500 x g
for 2.5 minutes. After this, lm L of ice-cold PBS was added to the cells and transferred to
a 1.5 mL Eppendorf tube and centrifuged at 500 xg for 2.5 minutes. As much supernatant
as possible was pipetted out and discarded. Later, lOOpL o f ice-cold CER I was added to
the pellet and vortexed for 15 seconds to suspend the cell. The mixture was then incubated
on ice for 10 minutes and 5.5 pL of ice-cold CER II was added to the mixture. The tube
was again vortexed for 5 seconds and incubated for 1 minute. Then the mixture, vortexed
again for 5 seconds and centrifuged for 5 minutes at maximum speed. The supernatant was
collected immediately after centrifugation and stored in a clean pre-chilled tube. This was
the cytoplasmic extract. The pellet was resuspended in 50 pL of ice-cold NER and vortexed
for 15 seconds. The sample was put on ice and was vortexed every 10 minutes for 15
seconds, for a total of 40 minutes. Later, it was centrifuged at maximum speed for 10
minutes and the supernatant was collected and placed in a clean pre-chilled tube. This was
the nuclear extract.

Near-Infrared Western Blot Analysis (NIWB)
Protein extractions were prepared from nucleus and the cytoplasm and were loaded
into each well of the 4-20% polyacrylamide-SDS gel in addition to the ladder. The gel then
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was run following the manufacturer’s procedure (37). After that, the gel was transferred
into the blotting membrane and was run following the manufacturer’s procedure. The
membrane was then incubated with the primary Rabbit-anti HA antibody (lug/m L o f LICOR blocking buffer) that was previously prepared and obtained from Invitrogen ™
company for 4-6 hours while rock/shock on a shaker at room temperature. It was then
incubated with previously prepared IRDye® 800CW Goat Anti-Rabbit IgG (H + L)
secondary antibody obtained from the LI-COR company (1 pL in 10 mL of LI-COR
blocking buffer). The membrane was then incubated for 30-45 minutes on the shaker at
room temperature. Then, the membrane was dried out by placing it between two paper
towel sheets and visualized under the infrared radiation using the device Odyssey® CLx
scanner by detecting the fluorescent dye of the secondary antibody at its excitation
wavelength of 676 nm. After that, immunoblotted pictures were generated using the
software Odyssey® CLx imaging system that was provided with the device. The intensity
of each band was obtained using the software Odyssey® CLx imaging system and was
accomplished by highlighting the area with dark band using the rectangular option found
in the software program. A table then formulated with the collected data using Microsoft
Excel software.

Half-life cycloheximide (CHX) Chase Assay
The cell cultures for SK-MEL-24 cells were transfected as mentioned previously.
Then the cells were treated with CHX (lOpg/mL) to inhibit the de novo protein synthesis.
Next, the cells were harvested at the following time profile: 0, 1, 3 and 6 hours. After that,
the harvested cells underwent Near- Infrared Western Blotting analysis (as mentioned
earlier) to collect the data. The visualization of Western Blot membrane was accomplished
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using the near infra-red device Odyssey ® CLx scanner following the same steps
mentioned in the previous experiments. The intensity o f each band was obtained by
highlighting the area with dark band using the rectangular option found in the Odyssey®
CLx imaging system and then formulated a table with the collected data using Microsoft
Excel software.
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Results
Transfection of ICER plasmid mutants into SK-MEL-24 cells
Recent research experiments show that human melanoma cells harvested from
various types of patients provide a versatile tool for studying morphology, gene expression,
and cellular and physiological modifications (31). To insert ICER constructs and further
investigate how they can be expressed, we performed an in vitro transfection o f the SKMEL-24 cells with ICER mutant. First, site-directed mutation was made for the
ubiqitinated sites of ICER (KO-52, 59, 70, 71, 72, 76, 87, 90, 97, 100 and 106) as well as
CWT, NWT, CKO and NK0. Next, the plasmids were ordered from the ThermoFisher
Scientifics company and tagged with Green Fluorescent Protein (GFP) following a similar
procedure as the HA-tag (See materials and methods). To test for the viability o f the
transfected SK-MEL-24 cells, we applied a chemical non-liposomal transfection technique
using FuGENE®HD Transfection Reagent. Fluorescent imaging method was conducted
using Phase Contrast microscopy to obtain spatial localization for ICER samples K0-(52,
59, 70, 71, 72, 76, 87, 90, 97, 100 and 106), NWT, CWT, NK0 and CKO and the control
sample which only contained SK-MEL-24 cell with GFP-tagged ICER and the total cell
count for each ICER mutant was estimated (Table 1). The data showed that KO-72, KO-71
and CWT had the highest number of transfected fluorescent cells calculated to be 332, 226
and 266 respectively. The second group consisting of KO-59, K0-100 and K0-70 constructs
had average numbers of transfected cells with values 145, 155 and 112 respectively. The
remaining ICER mutants K0-(52, 76, 87, 90, 97 and 106), NK0, CKO and NWT had the
lowest and insignificant numbers of transfected SK-MEL-24 cells (Table 1). These results
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suggested that these mammalian cells could have inserted ICER plasmid into their DNA
with different affinities altered by the change in the amino acid at each ubiquitination site.
Furthermore, to determine how SK-MEL-24 cells were efficient in taking up theses
ICER mutants, transfection efficiency (TE) was calculated. The values o f TE were obtained
by dividing the number of the fluorescent cells by the total cell count number obtained
from Phase Contrast microscopy imaging (Table 1). The TE o f KO-72, KO-71 and CWT
samples were high and calculated to be 85%, 65% and 75% respectively indicating that the
SK-MEL-24 cells were successfully transfected with ICER DNA. These results were
followed by transfection efficiencies with average values of 40% for KO-59 and K0-100
and 35% for K0-70. These results, in turn indicated that SK-MEL-24 cells have selectable
characteristics for ICER induction proving that they can be employed as a model cell for
studying melanoma.
Table 1: Transfection of ICER mutants into SK-MEL-24 cells.

Sample
NKO
CKO
NWT
CWT
KO-52
KO-59
K0-70
KO-71
KO-72
KO-76
K0-87
K0-90
KO-97
K 0-100
KO-106

Cell Count
75
13
62
266
84
145
112
226
332
52
96
92
56
155
14

Total # of Cells
125
125
246
355
167
363
321
347
390
264
275
366
223
387
142

% Transfection
Efficiency
60%
10%
25%
75%
50%
40%
35%
65%
85%
20%
35%
25%
25%
40%
10%
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Visual localization ofICER mutants in SK-MEL-24 cells
Previous studies suggested that ICER can be expressed in the nucleus of
mammalian cells (32). To test this hypothesis, we sought to assess the subcultural
localization ofICER mutants using Immunocytochemistry (ICC) technique. The SK-MEL24 cells were first transfected with HA-tagged ICER mutants; CKO, NKO, NWT, CWT,
K0-(52, 59, 70, 71,72, 76, 87, 90, 97, 100 and 106). Then, an ABC immunocytochemistry
method was applied to the transfected cells. Each transfected cell was viewed under the
light microscopy for visual analysis. The obtained immunostaining images showed
different subcellular distributions and localizations of all ICER mutants under 200X
magnification (Fig. 1). Then, the average number of cytosolic and nuclear localization for
ICER mutants was collected and calculated from 5 different locations o f each sample
(Table 2). The data indicated that most SK-MEL-24 cells had nuclear localization for ICER
mutants, including; CWT, KO-97, and kO-87, which showed elevated numbers of SK-MEL24 cells that expressed ICER in the nucleus with values of 44, 40 and 35 respectively (Fig.
2). These results indeed, agreed with the previous studies that suggested ICER nuclear
expression; however, some of the transfected SK-MEL-24 cells showed the abnormal
distribution for ICER expression. For instance, NWT and NKO samples showed higher
numbers for ICER cytoplasmic localization than the nuclear distribution with values of 12
and 24 respectively (Fig. 2). These results suggested that the transfected ICER mutants
were affected by the activity and expression o f other forms o f ICER that were originally
present in these melanoma cells with lower amounts.
In addition, another observation was made to study the morphology o f the
transfected SK-MEL-24 cells. To illustrate, we first compared the shapes of the mutants’
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nuclei to that of the control sample (Fig. 1). The immunostaining images showed that the
nucleus of cells transfected with ICER mutants had different shapes as in K0-(52, 90 and
97) samples which had an oval shaped nucleus observed under 200X total magnification
(Fig. 1). Compacted nucleus was another type o f modified nuclei observed for K0-(59, 70,
71, 72, 76, 87, 100 and 106) samples. From these observations, we concluded that the
activity of ICER mutants might be involved in disrupting the morphology o f SK-MEL-24
cells nuclei as well as dislocation of ICER.

Figure 1: Immunocytochemistry for ICER mutants in SK-MEL-24 cells. The images of the cells were viewed under
200X total magnification. Scale bar = 10 gm.
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Table 2: Cellular localization of ICER mutants. The data were estimated from 5 independent locations per sample.

Sample
Control
CKO
NWT
CWT
KO-52
KO-59
K0-70
KO-71
KO-72
KO-76
KO-87
K0-90
KO-97
K0-100
K0-106
NKO

Nuc Avg.
0
11
8
44
23
21
11
29
22
22
35
27
40
22
29
19

Nuc+ Cyt
Avg.
0
8
12
29
10
8
4
14
14
11
18
20
17
14
13
24

Figure 2: Plot indicating the numerical quantification of ICER cellular localization in SK-MEL-24 cells. Error bars
show the standard error of 5 independent experiments.

Quantitative analysis of ICER in SK-MEL-24 cells
Because Immunocytochemistry can only give spatial data on the location of
expressed ICER mutants, Western Blot analysis was performed to further evaluate the
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expression levels of ICER mutants in SK-MEL-24 cells. Hence, we proposed a series of
experiments to investigate quantitatively the amount of expressed ICER mutants at the
cytosolic and nuclear levels. We first co-transfected SK-MEL-24 cells with ICER mutants.
Then, the cells underwent NE-PER nuclear and cytosolic extractions. After that, a gel
electrophoresis experiment was applied and the bands on the gel were transferred onto a
nitrocellulose membrane through a Near-Infrared (NIR) Western Blot procedure. The
immunoblotting images for all ICER mutants were obtained using Odyssey" CLx imaging
infrared imaging system which showed how each mutant corresponded to the different
levels of ICER expression (Fig. 3). The detected bands on the blotted membrane showed
that ICER saturated at a molecular weight of T 8.5 KDa as compared to the provided protein
ladder (Fig. 3, blue arrow). In addition, the data showed bands saturated at a lower
molecular weight located below the bands for ICER protein and they represented that ICER
most likely degraded (Fig. 3, green arrow). Furthermore, o f ICER mutants had
polyubiquitinated bands observed in the top region of the immunoblotted membrane (Fig.
3, orange bracket). These observations in turn suggested that there was a process other than
ubiquitination involved in the fate of ICER expression.
Moreover, the ratio of expressed ICER at the cytosol and nucleus was calculated from the
intensity of each ICER mutants’ band obtained from the Odyssey® CLx infrared imaging
program (Table 3). The results showed that ICER was expressed according to three
categories; high intensity bands were detected in samples that were transfected with NWT,
CWT, K0-(59 and 90), average intensity bands that were represented by ICER mutants
CKO, NKO, K0-(52, 87 and 97), and low intensity bands that were collected from K0-(70,
71, 72, 100 and 106) (Fig. 4). The Western Blot analysis provided more convenient
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information on the nature of ICER mutant expression on the cytosolic and nuclear levels
which showed that it can be expressed at both sites. The data suggested that the decreased
ICER expression in the nucleus was due to the abnormal activities of ubiquitination and
sumoylation processes as post-translational modifications that took place after ICER
cellular induction.
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Figure 3: Western Blot analysis for SK-MEL-24 cells transfected with ICER mutants. N represents nuclear fractions
and C for cytosolic fractions. The assigned molecular weight for ICER is~ 18.5 KDa. The orange bracket shows the
bands for polyubiquitinated ICER, the blue arrow shows bands for ICER and green arrow shows the bands for
degraded ICER
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Table 3: Cellular localization of ICER mutants in SK-MEL-24 cells.

S am ple

C yt
Intensity

N uc
In ten sity

N u c/C yt
In tensity

C ontrol

0

0

0

CKO

1450000

2400000

166

NW T

484000

2920000

603

CW T

2 3 1 0000

8150000

353

KO-52

144000

189000

131

K 0-59

2700

7970

295

K 0-70

2 7 4000

139000

51

KO-71

1130000

36100

3

KO-72

1740000

122000

7

KO-76

1930000

27800

1

KO-87

173000

250000

145

K 0-90

4 0300

122000

303

KO-97

314000

559000

178

K 0-100

458000

322000

70

K 0-106

365000

203000

56

NKO

2 1 8 0000

3640000

167

ICER Constructs
Figure 4: Plot indicating the quantification of the cellular localization of ICER mutants in SK-MEL-24 cells. The
intensity ratio was calculated by dividing the intensity at the nucleus by the intensity of the cytoplasm times 100.
Error bars show the standard error.
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ICER Mutants' Stability and Turnover
To investigate the nature and role o f the ubiqitinated sites o f all ICER mutants
inside SK-MEL-24 cells, we performed a half-life experiment where the cells were first
transfected with ICER mutants then treated with cycloheximide (CHX) assay to inhibit the
de novo protein synthesis of ICER. Samples from each ICER mutant were collected at four
different time intervals (0, 1,3 and 6 hours) and Western Blot analysis was applied to test
the expression level of ICER mutant after CHX treatment (Fig. 5). The data showed that
all ICER mutants expression levels have completely disappeared 6 hours after CHX
application. The only samples that corresponded positively to the addition o f CHX were
CKO and NKO, which lack the presence o f ICER, while the wildtype samples; NWT and
CWT required shorter time to lose its levels for ICER expression indicating that cells
carried out ubiquitination process after ICER protein translation.
Furthermore, to evaluate the amount o f disappearance o f ICER throughout the
assigned time intervals, we measured the intensity o f each band using the Odyssey51 CLx
infrared imaging program (Table 4). The data showed that most o f ICER mutants had a
fast drop after two hours of treatment with CHX. The data collected at 3 hours showed a
one-fold reduction in the activity o f ICER expression and scored NWT and CWT with
relatively higher intensities comparing to other samples with values of 52 and 60
respectively, added to that, the data gave average intensities obtained from CKO and K071 with 22 values for both samples. On the other hand, the data at the 6th hour showed very
low intensities for all samples, including NWT, CWT, KO-71 and K0-106 (Fig.6). These
data in turn suggested that ICER underwent post-translation modifications which mainly
highlighted the important role o f ubiquitination as well as shaded the light on the possibility
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that sumoylation pathway was another method triggering the SK-MEL-24 cells to get rid
ofICER.

Figure 5: Western Blot analysis ofICER mutants’ half-life in SK-MEL-24 cells. The fractions were collected
according to four different time intervals at (0, 1,3 and 6) hours.
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Table 4: Intensities of ICER mutants’ half-life. The intensities represent at four different time intervals (0, 1,3 and 6
hours). Zero hours represent the time at which CHX was just added to each sample.

Hours
ICER
Constructs
NWT
CWT
NKO
CKO
KO-52
KO-59
K0-70
KO-71
KO-72
KO-76
KO-87
K0-90
KO-97
K0-100
K0-106

0

1

3

6

100
100
100
100
100
100
100
100
100
100
100
100
100
100
100

60
80
33
48
10
12
12
14
13
12
14
19
29
20
42

52
60
9
22
9
4
7
22
7
8
1
13
7
10
7

25
44
4
12
3
2
15
25
3
12
10
6
1
7
25
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Discussion
The purpose o f this project was to elucidate how ICER expression and localization
are altered by ubiquitination which tags the targeted proteins, allowing the cell to further
signal for proteasomal degradation and sumoylation which only labels the targeted proteins
and mislocate them on a subcellular level. By employing SK-MEL-24 mammalian
melanoma cells, it was possible to perform site-directed mutation to further investigate the
influence of post-translational modifications on ICER. Protein ubiquitination and
sumoylation are key post-translational modifications that are involved in many aspects o f
cell behavior and malfunction and are related to a wide range of human diseases, including
diabetes and cancer (33). We found that most ICER constructs were expressed at different
levels in melanoma cells (Table 1). The estimated cell count and TE values showed that
ICER mutants had diverse permeability toward SK-MEL-24 cells. This in turn indicated
that modifying each ubiqitinated site o f ICER through replacing the amino acid lysine (K)
to arginine (R) caused a transformation to the chemical and conformational properties
which affected the affinity of ICER mutants and their overall expression profile.
Earlier melanoma studies have stated that ICER expression occurs only on the
nucleus level of the cell (32); nevertheless, we have provided a fundamental evidence
suggesting that ICER cellular localization was detected in the nucleus and cytoplasm of
SK-MEL-24 cells (Fig. 1). Here, we hypothesized that the endogenous ICER acted as a
strong competitive substrate on the promoter o f CREB leading the cells to exclude the
transfected ICER mutants from the nucleus to the cytoplasm. This occurred because ICER
protein is relatively small and can diffuse through the pores o f the nucleus. In addition, it
has previously been shown that PTMs like ubiquitin and ubiquitin-like-dependent
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pathways have a significant function in regulating cellular responses to different changes
such as degradation of the endogenous proteins through proteasome (15, 18). In human
melanoma cells, ICER proteasomal degradation is promoted by MAPK or cdkl
phosphorylation where it is tagged with ubiquitin leading to degradation through
polyubiquitination or mistargeted to the cytosol through monoubiquitination (27). Using
Western Blot analysis, we found that ICER was only polyubiquitinated and represented by
a smear of bands with different molecular weights resided above the band for ICER (Fig.3).
This in turn, suggested that ICER was targeted for proteasomal degradation. Elowever, our
data did not show any monoubiquitinated form o f ICER obtained from the blotted
membrane, we observed a degraded form o f ICER represented by a group o f bands traced
below ICER band. We hypothesized that ICER might have reacted with the antibody and
produced protein with lower molecular weights (Fig.3). Moreover, previous studies have
indicated that the biological implications o f sumoylation pathway can modify the fate of
protein expression within the subcellular component o f tumor cells (21). We found that
most of ICER mutants were expressed in the cytosol o f SK-MEL-24 cells (Fig. 3). From
these data, we hypothesized that ICER was not targeted for proteasomal degradation,
rather, it was only labeled with ubiquitin-like molecule through occupying the same lysine
(K) residue required for the ubiquitination process, masking its function and consequently
mislocating ICER expression into the cytosol. Since sumoylation involves in nonproteolytic targeting, its biochemical function affects the non-covalent interactions
between the modified protein and the sumo interacting motifs (SIM) facilitating various
interactions and promoting configurational changes (21). Based on these previous
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discoveries, we hypothesized that the different cellular distribution o f ICER mutants’
expression was due to these interactions (Table 3 and Fig. 4).
Furthermore, determining the stability and turnover o f ICER protein are considered
the most crucial step towards exploring whether its biological activity and cellular
expression level are undergoing proteolytic control as in the case o f ubiquitination and
sumoylation. Through the application o f specific inhibitors that are designed to target
different proteolytic proteins it will be a very useful tool for identifying specific protein
degradation pathways. Therefore, we sought to employ the half-life approach using the
blocker cycloheximide (CHX) to further understand the turnover properties o f ICER
mutants on the cellular level. We found that all ICER mutants had a very short lifespan
averaged to be between 1-3 hours (Fig. 5 and table 4). Here, we hypothesized that the Nterminus was very important for the stability o f ICER and by adding the HA-tag, it might
lead to camouflaging this stability. This in turn indicated that lysine (K) residue is very
important for the activity of ICER. In addition, the results suggested that the cells were
triggering other pathways to get rid of ICER.
It has been clear that any alteration in gene expression coupled to the activation of
certain cellular signaling pathway leading to abnormal cellular proliferation and
dysregulating the fate of mammalian cells have long been identified as the most
distinguished features o f cancer progression. These activities are promoted by PTMs
because of their chemical modifications in regulating or changing proteins’ function and
structures, which in turn are responsible for dictating the different activation states for most
of the biological and physiological events. This project discusses two o f the most o f wellestablished examples PTMs; ubiquitination and sumoylation where they control the fate of
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ICER protein, resulting in the irregularities o f cell physiology, anatomy, cellular
localization integrity and gene expression levels.
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